TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07284784: A Study of Buntanetap in Participants With PD

Sponsor: Annovis Bio Inc. · Phase: PHASE2/PHASE3 · Area: CNS_NEUROLOGY · Target Enrollment: 500 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$568,032

Rescue Site Savings

+$378,688

Unlock Full NCT07284784 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07284784 Rescue Dossier →